Robo.ai Subsidiary Neurovia AI Announces NeuroStream™ Architecture at ISNR 2026 and Initiates Commercial Proof of Concept Phase
ABU DHABI, UAE, May 22, 2026 /PRNewswire/ -- Robo.ai announced that its subsidiary, Neurovia AI, disclosed its recent technological and commercial developments following the conclusion of the 2026 International Exhibition for National Security and...
Fukuoka City Announces Fukuoka Prize 2026 Laureates; Grand Prize Awarded to HO Tzu Nyen, Singaporean Artist
FUKUOKA, Japan, May 22, 2026 /PRNewswire/ -- Fukuoka City (Secretariat of Fukuoka Prize Committee) on Friday, May 22, announced the laureates for the Fukuoka Prize 2026 to honor those who have made outstanding achievements in the fields of Asian...
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations
SHANGHAI, May 22, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present multiple clinical study results of its novel Nectin-4-targeting ADC 9MW2821...
Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China
NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients SHANGHAI, May 22, 2026 /PRNewswire/ -- Nuance Pharma today announced that the National Medical Products Administration (NMPA) has cleared its...
BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
BEIJING, May 22, 2026 /PRNewswire/ -- BAI Capital today announced the first close of its latest USD fund, targeting US$800 million. The first close reached US$600 million in commitments. At a time when global capital allocation has become more...
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
TAIPEI, May 22, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected...
Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS
CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical...
Blockchain.com Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of Class A Ordinary Shares
NEW YORK, May 21, 2026 /PRNewswire/ -- Blockchain.com Group Holdings, Inc. today announced it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") related to the...
Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026
Net Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating Expenses BEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today...
VTech Announces FY2026 Annual Results
Higher gross profit margin despite lower revenue and profit Group revenue declined 6.9% to US$2,027.5 million Gross profit margin improved from 31.5% to 32.7% Profit attributable to shareholders of the Company decreased 14.5% to US$134.1 million...